Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01768806 · ClinicalTrials.gov registry record · NA

Randomized Controlled Trial of the P.L.A.Y. (Play and Language for Autistic Youngsters) Project Intervention for Autism

A NA study of Autism Spectrum Disorder and Autism, sponsored by Richard Solomon MD.

Completed
Registry status
NA
Development phase
112
Enrollment target
1
Study location

NCT01768806: Completed NA study of Autism Spectrum Disorder and Autism, sponsored by Richard Solomon MD.

NCT01768806 is a NA study of Autism Spectrum Disorder and Autism that has completed, run by Richard Solomon MD. The registered enrollment target is 112 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (17% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01768806, a NA study of Autism Spectrum Disorder and Autism, has completed, sponsored by Richard Solomon MD.

COMPLETED
Registry status
NA
Development phase
112 participants
Enrollment target
1
Study location

Study Summary

This study is a large, multi-site, randomized controlled NIH trial that evaluates whether The P.L.A.Y. (Play and Language for Autistic Youngsters) Project is effective. The PLAY Project Home Consultation model coaches parents, through monthly home visits and the use of video feedback, to effectively interact with their young child with autism. The aims of the study are 1.) to show that the PLAY Home Consultants show fidelity to the model, 2.) that caregivers can be taught to interact in an engaging way with their child (with causing more stress), 3.) that the child then interacts better, improves his/her language, and has reduced severity of his or her autism.

Primary Outcome

Autism Diagnostic Observation Scale (ADOS) (Lord ) yields scores in 3 scales: Communication, Social Interaction, and Circumscribed Interests. The ADOS has been repeatedly evaluated as diagnostic measures, it has also been used as an outcome measure of autism severity (Aldred et al., 2004; Gutstein, 2007; Owly et al, 2001, Green et al, 2010). The ADOS distinguishes three levels of severity: Autism, Autistic Spectrum Disorder, and non-autistic. Pre- and post-assessment using the ADOS will be used

Interventions

  • BEHAVIORAL PLAY Project Intervention for Autism
  • BEHAVIORAL Special education pre-school

Study Locations (1)

Michigan

  • Ann Arbor Center for Developmental and Behavioral Pediatrics - Ann Arbor

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2009-09
Est. Completion 2012-12
Phase NA
Richard Solomon MD

1 total trials

What the finished NCT01768806 record still lists

NCT01768806 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (17% lower).

The record links to 2 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which PLAY Project Intervention for Autism is the first listed.

NCT01768806 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT01768806 about?

NCT01768806 is a clinical study titled "Randomized Controlled Trial of the P.L.A.Y. (Play and Language for Autistic Youngsters) Project Intervention for Autism". This study is a large, multi-site, randomized controlled NIH trial that evaluates whether The P.L.A.Y. (Play and Language for Autistic Youngsters) Project is effective. The PLAY Project Home Consultation model coaches parents, through monthly home visits and the use of video feedback, to effectively...

What is the current status of trial NCT01768806?

This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2009-09. Estimated completion is 2012-12.

What conditions does trial NCT01768806 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder, Autism.

What interventions are being tested in trial NCT01768806?

The interventions under investigation include: PLAY Project Intervention for Autism (BEHAVIORAL), Special education pre-school (BEHAVIORAL).

Who is sponsoring clinical trial NCT01768806?

This trial is sponsored by Richard Solomon MD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01768806 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01768806's enrollment target sits among peer trials

112 68th of 224 higher than 157 of 224 other Autism Spectrum Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04511013 · 112 participants · Phase 2

    A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

  • NCT04551560 · 112 participants · NA

    Stress and Congestive Heart Failure

  • NCT04872166 · 112 participants · Phase 1

    A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer

  • NCT05024773 · 112 participants · Phase 3

    Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01768806, the US trial registry maintained by the National Library of Medicine. NCT01768806 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.